Better by Design: Single-Cell Characterization for Enhanced Cell Therapies

Discover the evolution of the cell therapy industry and how IsoPlexis is redefining what's possible through the ability to stratify patient response to novel immunotherapy regimens

[wpbb post:title]
Dr. James Heath, Professor and President of the Institute of System Biology
  • Explore how cytokines reveal function in immunotherapy and the challenges in revealing mechanism & responders through blood cytokines & phenotype

  • Reveal highly polyfunctional immune cells that correlate to in-vivo response to immunotherapy

  • Uncover potent cytokine mechanism using Single-Cell PSI to reveal responders in trials with checkpoint inhibitors